English
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

Cerebello-Spinal tDCS as Rehabilitative Intervention in Neurodegenerative Ataxia

Only registered users can translate articles
Log In/Sign up
The link is saved to the clipboard
StatusRecruiting
Sponsors
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia

Keywords

Abstract

Neurodegenerative cerebellar ataxias represent a group of disabling disorders which currently lack effective therapies. Cerebellar transcranial direct current stimulation (tDCS) is a non-invasive technique, which has been demonstrated to modulate cerebellar excitability and improve symptoms in patients with cerebellar ataxias. In this randomized, double-blind, sham-controlled study followed by an open-label phase, the investigators will evaluate whether a repetition of two-weeks' treatment with cerebellar anodal tDCS and spinal cathodal tDCS, after a three months interval, may further outlast clinical improvement in patients with neurodegenerative cerebellar ataxia and can modulate cerebello-motor connectivity, at short and long term.

Description

Neurodegenerative cerebellar ataxias represent a heterogeneous group of disabling disorders in which progressive ataxia of gait, limb dysmetria, oculomotor deficits, dysarthria and kinetic tremor are the prominent clinical manifestations. Both the hereditary and sporadic forms usually present in young adulthood, and are characterized by atrophy of cerebellar or brainstem structures. Currently, cerebellar ataxia lack effective disease-modifying therapies.

Cerebellar transcranial direct current stimulation (tDCS) is a non-invasive technique, which has been demonstrated to modulate cerebellar excitability and improve symptoms in patients with cerebellar ataxias. The present randomized, double-blind, sham-controlled study followed by an open-label phase will investigate a repetition of two-weeks' treatment with cerebellar anodal tDCS and spinal cathodal tDCS, after a three months interval, may further outlast clinical improvement in patients with neurodegenerative cerebellar ataxia and can modulate cerebello-motor connectivity, at short and long term. In addition the investigators will evaluate if tDCS intervention might improve cerebellar cognitive-affective syndrome in patients with ataxia.

Dates

Last Verified: 02/29/2020
First Submitted: 10/28/2019
Estimated Enrollment Submitted: 11/03/2019
First Posted: 11/05/2019
Last Update Submitted: 02/29/2020
Last Update Posted: 03/02/2020
Actual Study Start Date: 11/30/2018
Estimated Primary Completion Date: 08/31/2020
Estimated Study Completion Date: 12/31/2020

Condition or disease

Ataxia
Spinocerebellar Ataxias
Spinocerebellar Ataxia Type 1
Spinocerebellar Ataxia Type 2
Spinocerebellar Ataxia 3
Multiple System Atrophy
Ataxia With Oculomotor Apraxia
CANVAS

Intervention/treatment

Device: Anodal cerebellar and cathodal spinal tDCS

Device: Sham tDCS - Real tDCS

Phase

-

Arm Groups

ArmIntervention/treatment
Experimental: Real tDCS - Real tDCS
10 sessions of anodal cerebellar and cathodal spinal transcranial direct current stimulation (5 days/week for 2 weeks) followed by an open-label 10 sessions of anodal cerebellar and cathodal spinal transcranial direct current stimulation (5 days/week for 2 weeks)
Sham Comparator: Sham tDCS - Real tDCS
10 sessions of sham cerebellar and sham spinal transcranial direct current stimulation (5 days/week for 2 weeks) followed by an open-label 10 sessions of anodal cerebellar and cathodal spinal transcranial direct current stimulation (5 days/week for 2 weeks).
Device: Sham tDCS - Real tDCS
10 sessions of sham cerebellar and sham spinal transcranial direct current stimulation (5 days/week for 2 weeks)

Eligibility Criteria

Ages Eligible for Study 18 Years To 18 Years
Sexes Eligible for StudyAll
Accepts Healthy VolunteersYes
Criteria

Inclusion Criteria:

- Patients with a cerebellar syndrome and quantifiable cerebellar atrophy

Exclusion Criteria:

- Severe head trauma in the past

- History of seizures

- History of ischemic stroke or hemorrhage

- Pacemaker

- Metal implants in the head/neck region

- Severe comorbidity

- Intake of illegal drugs

- Pregnancy

Outcome

Primary Outcome Measures

1. Change in the International Cooperative Ataxia Rating Scale (ICARS) Score From Baseline [Baseline - 2 weeks]

International Cooperative Ataxia Rating Scale (ICARS): semi-quantitative 100-point scale, yielding a total score of 0 (no ataxia) to 100 (most severe ataxia).

2. Change in the Scale for the Assessment and Rating of Ataxia (SARA) Score From Baseline [Baseline - 2 weeks]

Scale for the Assessment and Rating of Ataxia (SARA): 8-item performance based scale, yielding a total score of 0 (no ataxia) to 40 (most severe ataxia).

3. Change in the Cerebellar cognitive affective syndrome (CCAS) Scale From Baseline [Baseline - 2 weeks]

CCAS/Schmahmann syndrome scale: 120 point scale, yielding a total score of 0 (most severe cognitive impairment) to 120 (no cognitive impairment).

Secondary Outcome Measures

1. Change in the International Cooperative Ataxia Rating Scale (ICARS) Score From Baseline [Baseline - 2 weeks - 3 month - 6 months - 9 months]

International Cooperative Ataxia Rating Scale (ICARS): semi-quantitative 100-point scale, yielding a total score of 0 (no ataxia) to 100 (most severe ataxia).

2. Change in the Scale for the Assessment and Rating of Ataxia (SARA) Score From Baseline [Baseline - 2 weeks - 3 month - 6 months - 9 months]

Scale for the Assessment and Rating of Ataxia (SARA): 8-item performance based scale, yielding a total score of 0 (no ataxia) to 40 (most severe ataxia).

3. Change in the Cerebellar cognitive affective syndrome (CCAS) Scale From Baseline [Baseline - 2 weeks - 3 month - 6 months - 9 months]

CCAS/Schmahmann syndrome scale: 120 point scale, yielding a total score of 0 (most severe cognitive impairment) to 120 (no cognitive impairment).

4. Change in Cerebellar Brain Inhibition (CBI) Measurements From Baseline [Baseline - 2 weeks - 3 month - 6 months - 9 months]

Cerebellar brain inhibition (CBI) is expressed as motor evoked potential amplitude (average of 10 recordings). Lower values reflect higher inhibition and thus reduced impairment.

5. Change in the Short-Form Health Survey 36 (SF36) Score From Baseline [Baseline - 2 weeks - 3 month - 6 months - 9 months]

The Italian version of the Short-Form Health Survey 36 (SF-36): consists of 36 scaled score, yielding a total score of 0 (more disability) to 100 (less disability).

Join our facebook page

The most complete medicinal herbs database backed by science

  • Works in 55 languages
  • Herbal cures backed by science
  • Herbs recognition by image
  • Interactive GPS map - tag herbs on location (coming soon)
  • Read scientific publications related to your search
  • Search medicinal herbs by their effects
  • Organize your interests and stay up do date with the news research, clinical trials and patents

Type a symptom or a disease and read about herbs that might help, type a herb and see diseases and symptoms it is used against.
*All information is based on published scientific research

Google Play badgeApp Store badge